Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes

OBJECTIVE: Serum concentrations of the hepatokine fibroblast growth factor (FGF) 21 are elevated in obesity, type-2 diabetes, and the metabolic syndrome. We asked whether FGF21 levels differ between subjects with metabolically healthy vs. unhealthy obesity (MHO vs. MUHO), opening the possibility tha...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mol Metab
Asıl Yazarlar: Berti, Lucia, Irmler, Martin, Zdichavsky, Marty, Meile, Tobias, Böhm, Anja, Stefan, Norbert, Fritsche, Andreas, Beckers, Johannes, Königsrainer, Alfred, Häring, Hans-Ulrich, de Angelis, Martin Hrabě, Staiger, Harald
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2015
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4481465/
https://ncbi.nlm.nih.gov/pubmed/26137439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2015.04.002
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller